Alternatively, the use of oncolytic viruses engineered to enforce expression of metabolic reprogramming agents has shown promise, as demonstrated Rivadeneira et al. with the use of a leptin-expressing oncolytic virus to selectively express leptin within the TME to metabolically reprogram TILs and to enhance tumor control [81]. This evidence concerns the gene LEP and neoplasm.